Zacksupgraded shares of Exactech (NASDAQ:EXAC) from a sell rating to a hold rating in a research note released on Monday morning, Market Beat Ratings reports.
According to Zacks, “Exactech, Inc. develops, manufactures, markets and distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally. Its principal products include its knee and hip replacement systems. Exactech, Inc. is headquartered in Gainesville, Florida. “
In other news, SVP Bruce E.
